NCT03078517

Brief Summary

Investigators aim to compare two supraglottic airway devices; the i-gel and the newly developed laryngeal mask airway protector in terms of airway sealing effect, the insertion success rate, and the incidence of complications in anesthetized patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 13, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 19, 2018

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2018

Completed
Last Updated

February 5, 2018

Status Verified

February 1, 2018

Enrollment Period

9 months

First QC Date

January 4, 2017

Last Update Submit

February 1, 2018

Conditions

Keywords

I-gelLaryngeal mask airway protector

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal airway leak pressure

    Oropharyngeal airway leak pressure is measured by closing the expiratory valve of the circle system at a fresh gas flow of 3 L/min and observing the airway pressure at equilibrium.

    At 5 min after the insertion of i-gel or LMA protector

Secondary Outcomes (7)

  • Number of insertion attempt for the successful placement

    During the insertion of i-gel or LMA protector

  • Insertion time

    During the insertion of i-gel or LMA protector

  • Ease of insertion

    During the insertion of i-gel or LMA protector

  • Ease of gastric tube insertion

    At 25 min after the insertion of i-gel or LMA protector

  • The accuracy of insertion location of the device in the oropharyngeal space

    At 15 min after the insertion of i-gel or LMA protector

  • +2 more secondary outcomes

Study Arms (2)

I-gel group

ACTIVE COMPARATOR

After the induction of anesthesia, I-gel is inserted into the oropharyngeal space.

Device: I-gel

LMA protector group

EXPERIMENTAL

After the induction of anesthesia, laryngeal mask airway protector is inserted into the oropharyngeal space.

Device: Laryngeal mask airway protector

Interventions

I-gelDEVICE

After the induction of anesthesia, i-gel is inserted along the palatopharyngeal curve.

I-gel group

After the inudction of anesthesia, laryngeal mask airway protector is inserted along the palatopharyngeal curve, and the cuff is inflated.

LMA protector group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requirement for mechanical ventilation under general anesthesia

You may not qualify if:

  • Surgical position other than supine position
  • Tumors or anatomical abnormalities in the upper airway
  • Known or predicted difficult airway
  • Body mass index \> 30 kg/m2
  • Required postoperative mechanical ventilation
  • Head and neck surgery
  • Aspiration tendency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul Metropolitan Government Seoul National University Boramae Medical Center

Seoul, 156-707, South Korea

Location

Related Publications (1)

  • Chang JE, Kim H, Lee JM, Min SW, Won D, Jun K, Hwang JY. A prospective, randomized comparison of the LMA-protector and i-gel in paralyzed, anesthetized patients. BMC Anesthesiol. 2019 Jul 4;19(1):118. doi: 10.1186/s12871-019-0785-8.

Study Officials

  • Jin-Young Hwang, M.D., Ph.D.

    SMG-SNU Boramae Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

January 4, 2017

First Posted

March 13, 2017

Study Start

May 1, 2017

Primary Completion

January 19, 2018

Study Completion

January 20, 2018

Last Updated

February 5, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations